Turkish group Şahinler Holding is expanding its operations in Egypt with new investments exceeding $100mn across the ready-made garments and tourism sectors, Al Sharq Business reported on August 27, citing Ahmed El-Deeb, business development director at the company’s Egyptian unit.
The group is now pushing ahead with a major expansion through Şahinler Egypt, which is set to complete its third sportswear factory by the end of 2026 with planned investments surpassing EGP 2bn ($41.2mn).
The new plant spans 15,000 square metres. The project has already absorbed $13mn in funding and will boost the company’s production capacity significantly, raising the number of production lines from 10 to 34. In addition, a fourth factory is planned on a 50,000-square-metre plot in the third phase of Robiki City, east of Cairo. That facility will focus on ready-made garments under the global fashion brand Zara.
The group also intends to invest in Egyptian tourism. Plans are underway to build a 700-room resort under the Mega Saray brand, with estimated investments reaching $60mn, Al Sharq Business writes.
Founded in 1982, Şahinler already operates two sportswear factories in Egypt with $50mn in investments, alongside five facilities in Turkey, Bulgaria, Germany, and France. The group manages global investments exceeding $1.5bn and records $2.7bn in annual revenues, sees Egypt as a strategic growth market thanks to its competitive workforce, export potential, and strong ties with Europe.
The Egyptian government plans to attract EGP 252.8bn ($5.2bn) in investments to the manufacturing sector for FY 2025/26, Economy Plus reported on September 3, citing the country’s Minister of ... more
Egypt is set to receive the first tranche of $500mn from the International Monetary Fund’s (IMF) Resilience and Sustainability Facility (RSF) before the end of 2025, Asharq Business reported on ... more
Egypt plans to attract EGP 350bn ($7.4bn) of investment into its pharmaceutical sector within the next five years, Gamal El-Lithy, head of the Chamber of Pharmaceutical Industry at the ... more